Literature DB >> 32600716

Hepatoprotective effects of silymarin coated gold nanoparticles in experimental cholestasis.

Simona Clichici1, Luminita David2, Bianca Moldovan3, Ioana Baldea1, Diana Olteanu1, Mara Filip1, Andras Nagy4, Vlad Luca5, Carmen Crivii6, Petru Mircea7, Gabriel Katona8, Gabriela Adriana Filip1.   

Abstract

The present study reports the green synthesis of hybrid organic-inorganic gold nanocomposites using silymarin as reducing and capping agent. The structure of the silymarin loaded gold nanoparticles was investigated by using the appropriate analysis tools such as UV-Vis and Fourier-transform infrared spectroscopy (FTIR), and Transmission electron microscopy (TEM) techniques. TEM micrographs demonstrated that the gold nanoparticles were spherical in shape, well distributed and their mean size was about 10 nm. The in vivo hepatoprotective and antifibrogenic properties after bile duct ligation in rats of the silymarin coated gold nanoparticles were assessed. The changes regarding the blood tests and the liver histopathology were compared to the standard administration of silymarin. Silymarin loaded gold nanoparticles improved liver function, reduced cholestasis and oxidative stress parameters, with the increase of antioxidant support, and reduced inflammation and fibrosis in the liver of rats with extrahepatic cholestasis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cholestasis; Gold nanoparticles; Hepatoprotective agent; Silymarin

Year:  2020        PMID: 32600716     DOI: 10.1016/j.msec.2020.111117

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  6 in total

1.  Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats.

Authors:  Giuseppina Palladini; Marta Cagna; Laura Giuseppina Di Pasqua; Luciano Adorini; Anna Cleta Croce; Stefano Perlini; Andrea Ferrigno; Clarissa Berardo; Mariapia Vairetti
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-24

2.  Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis.

Authors:  Abdullah Saad Abdullah; Ibrahim El Tantawy El Sayed; Abdel Moneim A El-Torgoman; Abul Kalam; S Wageh; Maher A Kamel
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

Review 3.  Changes in Glutathione Content in Liver Diseases: An Update.

Authors:  Mariapia Vairetti; Laura Giuseppina Di Pasqua; Marta Cagna; Plinio Richelmi; Andrea Ferrigno; Clarissa Berardo
Journal:  Antioxidants (Basel)       Date:  2021-02-28

4.  Effects of Gold Nanoparticles Functionalized with Bioactive Compounds from Cornus mas Fruit on Aorta Ultrastructural and Biochemical Changes in Rats on a Hyperlipid Diet-A Preliminary Study.

Authors:  Remus Moldovan; Daniela-Rodica Mitrea; Adrian Florea; Irina-Camelia Chiş; Şoimiţa Suciu; Luminiţa David; Bianca Elena Moldovan; Laura Elena Mureşan; Manuela Lenghel; Rodica Ana Ungur; Răzvan Vlad Opriş; Nicoleta Decea; Simona Valeria Clichici
Journal:  Antioxidants (Basel)       Date:  2022-07-08

Review 5.  New Green Approaches in Nanoparticles Synthesis: An Overview.

Authors:  Bogdan Andrei Miu; Anca Dinischiotu
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

6.  Preparation and Characterization of Silymarin-Conjugated Gold Nanoparticles with Enhanced Anti-Fibrotic Therapeutic Effects against Hepatic Fibrosis in Rats: Role of MicroRNAs as Molecular Targets.

Authors:  Abdullah Saad Abdullah; Ibrahim El Tantawy El Sayed; Abdel Moneim A El-Torgoman; Noweir Ahmad Alghamdi; Sami Ullah; S Wageh; Maher A Kamel
Journal:  Biomedicines       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.